Walgreens Boots Alliance (WBA) Misses Q3 EPS by 8c, Cuts FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
CVS Health (CVS) Trades Lower in Sympathy Following Results from Walgreens (WBA)
June 27, 2023 7:11 AM EDTCVS Health (NYSE: CVS) Trades Lower in Sympathy Following Results from Walgreens (NASDAQ: WBA)
Walgreens revises full-year adjusted EPS guidance to $4.00 to $4.05 from $4.45 to $4.65, to reflect consumer and category conditions, lower COVID-19 contribution, and a more cautious macroeconomic forward viewWBA -7%CVS -2%
Walgreens Boots Alliance (WBA) Lowers FY EPS Guidance to $4-$4.05 from $4.45-$4.65
June 27, 2023 7:03 AM EDTWalgreens Boots Alliance (WBA) Lowers FY EPS Guidance to $4-$4.05 from $4.45-$4.65
... More